North America Tumor Ablation Market Size, Share Report, 2024-2032

North America Tumor Ablation Market Share, Size, Trends, Industry Analysis Report, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others); By Mode of Treatment; By Application; By Region; Segment Forecast, 2024 - 2032

Published Date:Mar-2024
Pages: 116
Format: PDF
Report ID: PM4500
Base Year: 2023
Historical Data: 2019-2022

Report Outlook

North America tumor ablation market size was valued at USD 0.79 billion in 2023. The market is anticipated to grow from USD 0.88 billion in 2024 to USD 2.12 billion by 2032, exhibiting the CAGR of 11.6% during the forecast period

North America Tumor Ablation Market Overview

The increasing prevalence of cancer, rising incidences of smoking, and sedentary lifestyle will drive the tumor ablation market growth in North America due to high purchasing power parity, availability of reimbursement, and government support for quality healthcare.

The market is anticipated to grow in North America due to an increase in the number of cancer patients and technological advancements in tumor ablation equipment that offer accuracy, cost-effectiveness, and mobility. The rising incidence of cancer and the high demand for safe therapeutic options will also contribute to the growth of the market in the region.

North America Tumor Ablation Market Size

To Understand More About this Research:Request a Free Sample Report

Tumor ablation is a medical procedure that is used to treat tumors, which are abnormal masses of tissue that can develop in various parts of the body. The process of ablation involves destroying or removing the tumor using different methods, such as cold (cryoablation), heat (radiofrequency ablation), or other energy sources.

For instance, in April 2023, Ethicon, a Johnson & Johnson MedTech Company, treated the first North American patient in its POWER1 study, utilizing robot-assisted transbronchial microwave ablation for lung cancer, aiming to demonstrate safety and efficacy in collaboration with global thoracic oncology centers.

The heightened awareness of tumor ablation procedures and the enlargement of medical centers in North America facilitate the growth of the market. The surging innovations and the adoption of advanced technologies for surgical methods and devices will offer beneficial opportunities for the growth of the market.

The COVID-19 pandemic has had a significant impact on the North American tumor ablation market development. The U.S. and Canada are the majorly affected countries by Coronavirus. In the initial phase of the pandemic, healthcare services were affected, leading to the postponement or cancelation of elective procedures, including some tumor ablation treatments. This was necessary to prioritize resources for COVID-19 cases.

Thus, the North American tumor ablation market demand experienced a temporary decline during the COVID-19 pandemic. However, elective surgeries were canceled or delayed, resulting in a decrease in tumor ablation procedures in North America, which impacted the region's tumor ablation equipment and accessories market.

North America Tumor Ablation Market Dynamics

Market Drivers

Increasing prevalence of cancer will drive the growth of the market

The rising prevalence of cancer will drive the growth of the market in North America. Tumor Ablation is a technique used to remove tumors without completely getting rid of them. Patients who undergo this treatment have lower hospitalization rates and are more likely to use ablation systems. With the increasing prevalence of prostate cancer, colon cancer, lung cancer, and breast cancer in North America, the demand for tumor ablation technologies is anticipated to rise. These technologies are particularly used to treat kidney, soft tissue, liver, and bone tumors.

The National Cancer Institute reported around 1,806,590 newly diagnosed cancer cases in the year 2020 in the United States, while the American Cancer Society stated that 1.8 million new malignancies were identified in the country. This rise in cancer cases in the United States is anticipated to boost the demand for tumor ablation devices.

Market Restraints

High cost associated with tumor ablation procedures hindering the growth of the market

The North America tumor ablation market has faced a significant hindrance due to the high costs associated with these procedures. Despite recent advancements in medical technology and increasing demand for minimally invasive treatments, the expenses involved in tumor ablation have posed a major challenge. Tumor ablation involves the targeted destruction of cancerous cells using techniques such as radiofrequency ablation, microwave ablation, and cryoablation. These procedures require sophisticated equipment, highly skilled medical professionals, and specialized facilities.

Furthermore, the high costs of tumor ablation procedures also include pre-operative and post-operative care, follow-up appointments, and necessary medications. These factors contribute to the overall financial burden for patients seeking tumor ablation as a treatment option. Additionally, insurance coverage for these procedures may vary, further limiting access to tumor ablation for some individuals.

North America Tumor Ablation Market Size

Report Segmentation

The market is primarily segmented based on technology, mode of treatment, application, and region.

By Technology

By Mode of Treatment

By Application

By Country

Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Others

Surgical Ablation
Laparoscopic Ablation
Percutaneous Ablation

Liver Cancer
Lung Cancer
Kidney Cancer
Bone Metastasis
Others

U.S.
Canada

To Understand the Scope of this Report:Speak to Analyst

North America Tumor Ablation Market Segmental Analysis

By Product Analysis

The radiofrequency ablation segment held the largest market share in the North America tumor ablation market. Radiofrequency Ablation is an extensively utilized and effective technique in North America. This medical procedure involves using high-frequency electrical currents to generate heat and destroy cancerous tissues. It is minimally invasive and has gained popularity due to its precision in targeting tumors while sparing surrounding healthy tissues. RFA is widely used in treating various cancer types, including liver, lung, kidney, and bone tumors.

Radiofrequency ablation has become increasingly popular in North America due to its ability to offer a less invasive alternative to traditional surgical interventions. This results in less patient discomfort, shorter recovery times, and an overall improved quality of life. Additionally, its outpatient-friendly nature aligns with the growing trend toward outpatient care, contributing to radiofrequency ablation's widespread acceptance as a valuable tool in the region's comprehensive approach to cancer treatment.

By Mode of Treatment Analysis

The percutaneous ablation segment held the largest market share in the North America tumor ablation market. Percutaneous ablation delivers fast recovery, better security, and less scarring. Furthermore, factors like patient convenience and cost-efficiency are anticipated to drive the percutaneous ablation demand higher in the North America region. Additionally, percutaneous ablation procedures can be performed on an outpatient basis, reducing the need for hospitalization and allowing patients to return to their daily activities sooner. Moreover, the cost-effectiveness of percutaneous ablation compared to other treatment options makes it a preferred choice for both patients and healthcare providers in North America.

North America Tumor Ablation Market Size

North America Tumor Ablation Market Regional Insights

U.S. dominated the tumor ablation market in 2023

The U.S. dominated the tumor ablation market. The advanced healthcare infrastructure, rise in the occurrence of numerous types of cancers, surging inclination of patients towards cancer treatment, and the funds received from the government for cancer research will bolster the growth of the market in North America. Also, the increasing rate of obesity and the rising geriatric population are anticipated to drive the adoption of diagnosis and cancer therapies.

This technique is extensively utilized in North America for treating liver, kidney, lung, and prostate tumors. The technique is popular due to its ability to remove cancerous tissue while preserving healthy organs and tissues.

Competitive Landscape

The North America tumor ablation market is fragmented and is anticipated to witness competition due to several players' presence. Major service providers in the market are constantly upgrading their technologies to stay ahead of the competition and to ensure efficiency, integrity, and safety. These players focus on partnership, product upgrades, and collaboration to gain a competitive edge over their peers and capture a significant market share.

Some of the major players operating in the market include:

AngioDynamics Inc.
Bioventus Inc.
Boston Scientific Corp.
EDAP TMS S.A.
Galil Medical Inc.
HealthTronics
Medtronic Plc.
Mermaid Medical
Misonix, Inc.
Neuwave Medical, Inc.
SonaCare Medical

Recent Developments

In March 2023, AngioDynamics partnered with Minimax Medical to facilitate the global distribution of its array of products. The partnership contains the international distribution of Minimax Medical's advanced Radiofrequency Ablation System, specifically designed for treating tumors and nodules.

Report Coverage

The North America tumor ablation market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.

The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, technology, mode of treatment, application, and their futuristic growth opportunities.

North America Tumor Ablation Market Report Scope

Report Attributes	Details
Market size value in 2024	USD 0.88 billion
Revenue forecast in 2032	USD 2.12 billion
CAGR	11.6% from 2024 – 2032
Base year	2023
Historical data	2019 – 2022
Forecast period	2024 – 2032
Quantitative units	Revenue in USD billion and CAGR from 2024 to 2032
Segments covered	By Technology, By Mode of Treatment, By Application, By Region
Country scope	U.S., Canada
Customization	Report customization as per your requirements with respect to countries, region and segmentation.

FAQ's

What is the expected industry size of North America Tumor Ablation Market?

North America Tumor Ablation Market Size Worth USD 2.12 Billion By 2032

Who are the top market players in North America Tumor Ablation Market?

The top market players in North America Tumor Ablation Market include AngioDynamics Inc., Bioventus Inc., Boston Scientific Corp., EDAP TMS S.A.

What will be the expected CAGR of North America Tumor Ablation Market during the forecast period (2024-2032)

North America tumor ablation market exhibiting the CAGR of 11.6% during the forecast period

What are the key segments in the North America Tumor Ablation Market Market?

North America Tumor Ablation Market report covering key segments are on technology, mode of treatment, application, and region.

1. Introduction
              1.1. Report Description
                    1.1.1. Objectives of the Study
                    1.1.2. Market Scope
                    1.1.3. Assumptions
              1.2. Stakeholders
2. Executive Summary
              2.1. Market Highlights
3. Research Methodology
              3.1. Overview
                    3.1.1. Data Mining
              3.2. Data Sources
                    3.2.1. Primary Sources
                    3.2.2. Secondary Sources
4. North America Tumor Ablation Market Insights
              4.1. North America Tumor Ablation Market – Industry Snapshot
              4.2. North America Tumor Ablation Market Dynamics
                    4.2.1. Drivers and Opportunities
                            4.2.1.1. Increasing prevalence of cancer will drive the growth of the market
                            4.2.1.2. Increasing inclination of patients and surgeons towards minimally invasive procedures will foster the market growth
                    4.2.2. Restraints and Challenges
                            4.2.2.1. High cost associated with tumor ablation procedures hindering the growth of the market
              4.3. Porter’s Five Forces Analysis
                    4.3.1. Bargaining Power of Suppliers (Moderate)
                    4.3.2. Threats of New Entrants: (Low)
                    4.3.3. Bargaining Power of Buyers (Moderate)
                    4.3.4. Threat of Substitute (Moderate)
                    4.3.5. Rivalry among existing firms (High)
              4.4. PESTLE Analysis
              4.5. North America Tumor Ablation Industry trends
              4.6. Value Chain Analysis
              4.7. COVID-19 Impact Analysis
5. North America Tumor Ablation Market, by Technology
              5.1. Key Findings
              5.2. Introduction
                    5.2.1. North America Tumor Ablation, by Technology, 2019-2032 (USD Billion)
              5.3. Radiofrequency (RF) Ablation
                    5.3.1. North America Tumor Ablation Market, by Radiofrequency (RF) Ablation, 2019-2032 (USD Billion)
              5.4. Microwave Ablation
                    5.4.1. North America Tumor Ablation Market, by Microwave Ablation, 2019-2032 (USD Billion)
              5.5. Cryoablation
                    5.5.1. North America Tumor Ablation Market, by Cryoablation, 2019-2032 (USD Billion)
              5.6. Others
                    5.6.1. North America Tumor Ablation Market, by Others, 2019-2032 (USD Billion)
6. North America Tumor Ablation Market, by Application
              6.1. Key Findings
              6.2. Introduction
                    6.2.1. North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
              6.3. Liver Cancer
                    6.3.1. North America Tumor Ablation Market, by Liver Cancer, 2019-2032 (USD Billion)
              6.4. Lung Cancer
                    6.4.1. North America Tumor Ablation Market, by Lung Cancer, 2019-2032 (USD Billion)
              6.5. Kidney Cancer
                    6.5.1. North America Tumor Ablation Market, by Kidney Cancer, 2019-2032 (USD Billion)
              6.6. Bone Metastasis
                    6.6.1. North America Tumor Ablation Market, by Bone Metastasis, 2019-2032 (USD Billion)
              6.7. Others
                    6.7.1. North America Tumor Ablation Market, by Others, 2019-2032 (USD Billion)
7. North America Tumor Ablation Market, by Mode of Treatment
              7.1. Key Findings
              7.2. Introduction
                    7.2.1. North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
              7.3. Surgical Ablation
                    7.3.1. North America Tumor Ablation Market, by Surgical Ablation, 2019-2032 (USD Billion)
              7.4. Laparoscopic Ablation
                    7.4.1. North America Tumor Ablation Market, by Laparoscopic Ablation, 2019-2032 (USD Billion)
              7.5. Percutaneous Ablation
                    7.5.1. North America Tumor Ablation Market, by Percutaneous Ablation, 2019-2032 (USD Billion)
8. North America Tumor Ablation Market, by Countries
              8.1. Key findings
              8.2. Introduction
                    8.2.1. North America Tumor Ablation Market Assessment, By Countries, 2019-2032 (USD Billion)
                    8.2.2. North America Tumor Ablation Market – U.S.
                                          8.2.2.1. U.S.: North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
                                          8.2.2.2. U.S.: North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
                                          8.2.2.3. U.S.: North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
                    8.2.3. North America Tumor Ablation Market – Canada
                                  8.2.3.1. Canada.: North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
                                  8.2.3.2. Canada.: North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
                                  8.2.3.3. Canada.: North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
9. Competitive Landscape
              9.1. Expansion and Acquisition Analysis
                    9.1.1. Expansion
                    9.1.2. Acquisitions
              9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
              10.1. AngioDynamics Inc.
                    10.1.1. Company Overview
                    10.1.2. Financial Performance
                    10.1.3. Technology Benchmarking
                    10.1.4. Recent Development
              10.2. Bioventus Inc.
                    10.2.1. Company Overview
                    10.2.2. Financial Performance
                    10.2.3. Technology Benchmarking
                    10.2.4. Recent Development
              10.3. Boston Scientific Corp.
                    10.3.1. Company Overview
                    10.3.2. Financial Performance
                    10.3.3. Technology Benchmarking
                    10.3.4. Recent Development
              10.4. EDAP TMS S.A.
                    10.4.1. Company Overview
                    10.4.2. Financial Performance
                    10.4.3. Technology Benchmarking
                    10.4.4. Recent Development
              10.5. Galil Medical Inc.
                    10.5.1. Company Overview
                    10.5.2. Financial Performance
                    10.5.3. Technology Benchmarking
                    10.5.4. Recent Development
              10.6. HealthTronics
                    10.6.1. Company Overview
                    10.6.2. Financial Performance
                    10.6.3. Technology Benchmarking
                    10.6.4. Recent Development
              10.7. Medtronic Plc.
                    10.7.1. Company Overview
                    10.7.2. Financial Performance
                    10.7.3. Technology Benchmarking
                    10.7.4. Recent Development
              10.8. Mermaid Medical
                    10.8.1. Company Overview
                    10.8.2. Financial Performance
                    10.8.3. Technology Benchmarking
                    10.8.4. Recent Development
              10.9. Misonix, Inc.
                    10.9.1. Company Overview
                    10.9.2. Financial Performance
                    10.9.3. Technology Benchmarking
                    10.9.4. Recent Development
              10.10. Neuwave Medical, Inc.
                    10.10.1. Company Overview
                    10.10.2. Financial Performance
                    10.10.3. Technology Benchmarking
                    10.10.4. Recent Development
              10.11. SonaCare Medical
                    10.11.1. Company Overview
                    10.11.2. Financial Performance
                    10.11.3. Technology Benchmarking
                    10.11.4. Recent Development

List of Tables

Table 1 North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
Table 2 North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
Table 3 North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
Table 4 North America Tumor Ablation Market Assessment, By Countries, 2019-2032 (USD Billion)
Table 5 U.S.: North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
Table 6 U.S.: North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
Table 7 U.S.: North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
Table 8 Canada.: North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
Table 9 Canada.: North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
Table 10 Canada.: North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)

List of Figures

Figure 1 North America Tumor Ablation Market, 2019-2032 (USD Billion)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
Figure 4 Market by Countries
Figure 5 Porter’s Five Forces
Figure 6 Market by Application
Figure 7 North America Tumor Ablation Market, by Application, 2021 & 2030 (USD Billion)
Figure 8 Market by Technology
Figure 9 North America Tumor Ablation Market, by Technology, 2021 & 2030 (USD Billion)
Figure 10 Market by Mode of Treatment
Figure 11 North America Tumor Ablation Market, by Mode of Treatment, 2021 & 2030 (USD Billion)
Figure 12 North America Tumor Ablation Market Assessment, By Countries, 2019-2032 (USD Billion)
Figure 13 Strategic Analysis – North America Tumor Ablation Market

Report Scope

North America Tumor Ablation Market, Technology Outlook (Revenue - USD Billion, 2019-2032)

Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Others

North America Tumor Ablation Market, Application Outlook (Revenue - USD Billion, 2019-2032)

Liver Cancer
Lung Cancer
Kidney Cancer
Bone Metastasis
Others

North America Tumor Ablation Market, Mode of Treatment Outlook (Revenue - USD Billion, 2019-2032)

Surgical Ablation
Laparoscopic Ablation
Percutaneous Ablation

North America Tumor Ablation Market, Countries Outlook (Revenue - USD Billion, 2019-2032)

U.S
- Technology Outlook
  - Radiofrequency (RF) Ablation
  - Microwave Ablation
  - Cryoablation
  - Others
- Application Outlook
  - Liver Cancer
  - Lung Cancer
  - Kidney Cancer
  - Bone Metastasis
  - Others
- Mode of Treatment Outlook
  - Surgical Ablation
  - Laparoscopic Ablation
  - Percutaneous Ablation
Canada
- Technology Outlook
  - Radiofrequency (RF) Ablation
  - Microwave Ablation
  - Cryoablation
  - Others
- Application Outlook
  - Liver Cancer
  - Lung Cancer
  - Kidney Cancer
  - Bone Metastasis
  - Others
- Mode of Treatment Outlook
  - Surgical Ablation
  - Laparoscopic Ablation
  - Percutaneous Ablation

Qualitative Analysis

Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL Analysis
- Value Chain Analysis
- Key market opportunities prioritized
Competitive landscape
- Overview
- Financials
- Technology benchmarking
- Latest strategic developments
- Price Trend Analysis

Quantitative Analysis

Market size, estimates, and forecasts from 2019-2032
Market revenue estimates for technology up to 2032
Market revenue estimates for application up to 2032
Market revenue estimates for Mode of Treatment up to 2032
Countries market size and forecast up to 2032
Company financials

Request Free Sample

We take great pride in "Delivering game-changing business opportunities reports with report customizations", so please don't hesitate to share with us your unique interests and business difficulties in much more detail.

By using this form you agree with the storage and handling of your data by this website.

This website is secure and your personal details are safe. Privacy Policy

North America Tumor Ablation Market Size, Share Report, 2024-2032

What's Included in Full Report?

Request Sample Report

North America Tumor Ablation Market Share, Size, Trends, Industry Analysis Report, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others); By Mode of Treatment; By Application; By Region; Segment Forecast, 2024 - 2032

Report Outlook

North America Tumor Ablation Market Overview

North America Tumor Ablation Market Dynamics

Market Restraints

Report Segmentation

North America Tumor Ablation Market Segmental Analysis

North America Tumor Ablation Market Regional Insights

Competitive Landscape

Recent Developments

Report Coverage

North America Tumor Ablation Market Report Scope

FAQ's

Table of Contents

List of Tables

List of Figures

Report Scope

Qualitative Analysis

Quantitative Analysis

Request Free Sample